Therese Söderdahl

Director Drug Safety at Affibody AB
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Sweden, SE
Languages
  • Swedish -
  • English -

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

5.0

/5.0
/ Based on 2 ratings
  • (2)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

Per Åberg

I had the pleasure to work with Therese as colleague and her direct manager when she was employed as Project toxicologist at AstraZeneca between the years of 2009-2013. In her role she was responsible for leading the integrated preclinical safety evaluation and characterization of drug discovery candidates, representing the Safety organization in Drug project teams. Her focus was on Drug Discovery research in the respiratory disease area, also gaining specific experience on inhaled drug candidates. Her role required a broad spectrum of capabilities, including toxicological expertise, innovative mindset, risk assessment skills, strong leadership, communication skills, broad understanding of drug therapies and the research process, capabilities and qualities which all were very clearly shown by Therese. Her background with PhD and post-doctoral research in models for hepatotoxicity also gave her a highly relevant and robust background for her role. Therese was a dedicated colleague that worked independently still with a consultative approach, and she was highly appreciated both professionally and privately. She is proactive, engaged and brings energy to work. As her manager, the feedback received was always with high appreciation of her contributions, both with regards to scientific expertise and as a team player, and with that she was consistently rated as a high performer. I would highly recommend Therese for similar roles, in which she could act and deliver from day 1, and I also believe that her general capabilities and approaches to leadership, and interaction and communication with people, makes her suitable for a range of different positions and challenges.

Anders Thelin

I have had the pleasure to work with Therese for three years. Therese is a highly skilled project-toxicologist with a solid scientific background. Therese took a leading role in many projects and in the safety assessment function. Therese have always used a holistic approach in her project work making sure the project not only develops safe drugs but aslo that the scientific standard overall is the highest possible. For this and for the fact that Therese is an extremely positive person she will always be a dream project-member and colleague.

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Sweden
    • Biotechnology
    • 1 - 100 Employee
    • Director Drug Safety
      • Aug 2021 - Present

      Director Drug Safety Director Drug Safety

    • Sweden
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Global Drug Safety Scientist
      • Aug 2020 - Aug 2021

    • United Kingdom
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Senior Patient Safety Scientist
      • Jun 2014 - Aug 2020

      Currently lead Patient Safety (PS) team work and deliveries to drug development project in Ph2b/3, in role as Safety Strategy and Management Team (SSaMT) leader - Represent PS in project and clinical teams to provide safety strategic and technical expertise - Manage PS team work and deliveries, providing high quality proactive safety support, optimising resources and ensuring efficient team collaboration - Lead cross-functional SSaMT team, responsible for safety related decision making and communications to project teams, stakeholders and competent authorities - Coordinate and oversee, as well as perform, program level pharmacovigilance related activities e.g. safety surveillance, periodic reports, risk assessment and management, signal management, clinical protocols. Previously allocated as pharmacovigilance scientist in projects post-marketing and during submission for launch, as well as SSaMT leader for several projects in early clinical development. Show less

    • Project Manager
      • Feb 2014 - May 2014

      Project management of research projects, coaching PhD and MSc students Assisted in conduct of clinical trials Managed Next Generation Biomedical Scientists Program Project management of research projects, coaching PhD and MSc students Assisted in conduct of clinical trials Managed Next Generation Biomedical Scientists Program

    • United Kingdom
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Project Toxicologist
      • Mar 2009 - Dec 2013

      Worked as Project Toxicologist with focus on discovery projects. Represented Safety Assessment in drug projects, with overall responsibility for pre-clinical safety. Identified and assessed target and chemistry related safety issues and led fit for purpose pre-clinical safety investigations. Interim project leader for a discovery drug project, leading cross-functional activities and project progress. Chaired an internal cross-functional discovery safety science review group, providing scientific support to project toxicologists. Study director for investigative front-loading in vivo studies. Show less

    • Germany
    • Hospitals and Health Care
    • 700 & Above Employee
    • Postdoc
      • Mar 2008 - Feb 2009

      Postdoctoral position in the Bioreactor Group at Charité in Berlin. Worked in collaboration with Safety Assessment, AstraZeneca, Södertälje, to evaluate drug-induced hepatotoxicity in 3D bioreactor culture systems. Postdoctoral position in the Bioreactor Group at Charité in Berlin. Worked in collaboration with Safety Assessment, AstraZeneca, Södertälje, to evaluate drug-induced hepatotoxicity in 3D bioreactor culture systems.

    • Scientist
      • Jun 2007 - Mar 2008

      Employed at the Institute of Environmental Medicine, Karolinska Institutet, to manage study on response to DNA damage and DNA repair in cells derived from human embryonic stem cells. Employed at the Institute of Environmental Medicine, Karolinska Institutet, to manage study on response to DNA damage and DNA repair in cells derived from human embryonic stem cells.

    • United Kingdom
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Biomedical analyst
      • Aug 2000 - Jul 2001

      Biomedical analyst at the Department of Genetic Toxicology, Safety Assessment. Performed mouse lymphoma TK assay according to GLP and also worked with development of a down-sized, higher throughput variant of this assay. Fixed term employment. Biomedical analyst at the Department of Genetic Toxicology, Safety Assessment. Performed mouse lymphoma TK assay according to GLP and also worked with development of a down-sized, higher throughput variant of this assay. Fixed term employment.

Education

  • Karolinska institutet
    PhD, Toxicology
    2001 - 2007
  • Stockholm University
    MSc, Chemistry
    1996 - 2000

Community

You need to have a working account to view this content. Click here to join now